Molecular Modelling Market Forecasts to 2030 – Global Analysis By Product (Software, Services and Other Products), Approach (Molecular Mechanics Approach, Quantum chemistry Approach and Other Approaches), Application (Drug Development, Drug Discovery and

Molecular Modelling Market Forecasts to 2030 – Global Analysis By Product (Software, Services and Other Products), Approach (Molecular Mechanics Approach, Quantum chemistry Approach and Other Approaches), Application (Drug Development, Drug Discovery and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutions and Other End Users) and By Geography

According to Stratistics MRC, the Global Molecular Modelling Market is accounted for $5.84 billion in 2023 and is expected to reach $15.07 billion by 2030 growing at a CAGR of 14.5% during the forecast period. Molecular modeling is a method used in the creation of pharmaceuticals. It helps in describing the creation or manipulation of molecules, their three-dimensional structures, and their physicochemical characteristics. They aid in the study of molecule behaviour and structure. Additionally, they are used in material science and computational biology. To analyze the biological and molecular properties, various computerized techniques are used.

According to World Health Organsiation figures released in February 2022, there will be around 50 million persons with epilepsy in 2022. According to the research, by 2022, roughly 80% of people with epilepsy will live in countries with low or middle incomes

Market Dynamics

Driver

Drug development and research

Molecular modeling is a key tool used by the pharmaceutical and biotechnology industries to speed up drug discovery and development procedures. Moreover, with the aid of this technology, researchers can screen potential drug candidates, predict how molecules will interact, and enhance the properties of drugs. As a result, it takes less time and money to introduce new drugs to the market, which is crucial given the growing demand for healthcare services and the requirement for cutting-edge treatments.

Restraint

Complexity and demands for computation

Simulators and complex mathematical algorithms are frequently used in molecular modeling. The computational requirements grow exponentially as systems get bigger and more complicated. However, the accessibility of advanced modeling techniques to smaller research groups or organizations with constrained computational infrastructure may be hampered by this complexity, which can strain available computational resources.

Opportunity

Expanding the use of precision medicine

By customizing medical care to each patient's unique genetic and molecular profile, precision medicine presents the potential to completely transform healthcare. Additionally, the identification of patient-specific drug responses can be made easier with the help of molecular modeling, which also helps to minimize side effects and improve therapeutic results. This method has a significant impact on patient care and crosses many medical specialties, including neurology and oncology.

Threat

Biological systems complexity

It is extremely difficult to model complex biological systems, such as complex protein-protein interactions or cellular processes. Accurate modeling and prediction of these systems are extremely challenging due to nonlinear dynamics, numerous variables, and uncertainties. Moreover, to deal with these complexities, it is essential to develop more complex modeling methods and multidisciplinary partnerships.

Covid-19 Impact

The COVID-19 pandemic had a wide range of effects on the market for molecular modeling. The pandemic, on the one hand, highlighted the vital role that molecular modeling plays in quickly understanding the virus's structure, identifying potential drug targets, and speeding up vaccine development. Furthermore, the significance of molecular modeling in drug discovery and therapeutic research was thus increased. On the other hand, some research and development activities were temporarily hampered by supply chain disruptions, issues with remote work, and financial constraints, particularly in academia and smaller research organizations.

The Services segment is expected to be the largest during the forecast period

The molecular modeling market's largest share is anticipated to belong to the services segment. Services for molecular modeling include consulting, computational analysis, software customization, and training, among many other services. Moreover, the dominance of this market is due to the demand for specialized knowledge and assistance when implementing and deciphering the outcomes of molecular modeling. In order to successfully navigate the complexities of molecular modeling, many organizations prefer to use the expertise and experience of service providers, which has led to the services segment holding the largest market share.

The Drug Discovery segment is expected to have the highest CAGR during the forecast period

The molecular modeling market's highest CAGR is anticipated to be held by the drug discovery segment. The increased need for molecular modeling tools and services during the early stages of drug development is credited with this growth. The drug discovery process is sped up by the use of molecular modeling, which is essential for identifying potential drug candidates, improving molecular structures, and forecasting interactions. Additionally, the demand for molecular modeling in drug discovery is anticipated to drive significant growth in this market as the pharmaceutical industry continues to place a high priority on innovation and effectiveness when bringing new medications to market.

Region with largest share

The molecular modeling market is expected to have the largest share in the European region. A significant number of pharmaceutical and biotechnology firms are located in Europe, along with universities that prioritize research and a well-established healthcare system. Furthermore, the area gains from joint research projects and government funding, which encourages creativity in molecular modeling applications across various industries. The adoption of molecular modeling in drug development, materials science, and environmental research has also been stimulated by Europe's commitment to precision medicine and sustainability initiatives, which has helped to contribute to its sizeable market share.

Region with highest CAGR

The molecular modeling market has the highest CAGR in the Asia-Pacific region. Several factors, including a booming pharmaceutical and biotechnology industry, increased research and development efforts, and an increasing emphasis on precision medicine in nations like China, India, and Japan, are driving this rapid growth. Asia-Pacific is a desirable location for the use of molecular modeling services and software due to its skilled workforce, technological advancements, and lower cost of conducting research. Moreover, the impressive expansion of the molecular modeling market in Asia-Pacific is being driven by the region's growing healthcare infrastructure and significant investments in scientific research and innovation.

Key players in the market

Some of the key players in Molecular Modelling market include Thermo Fisher Scientific Inc, Dassault Systems, BioSolveIT GmbH, Schrodinger Llc , Advanced Chemistry Development, Inc., OpenEye Cadence Molecular Sciences, Centera Lp, Simulations Plus Inc, Chemical Computing Group ULC, Bioinformatics Inc, Optibrium, Ltd., Cresset Acellera Ltd and Rosa & Co., LLC.

Key Developments

In July 2023, Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for $912.5 million in cash.

In June 2023, Dassault Systems Signs a New Agreement. Tran cosmos has signed a new system integrator alliance (SIA) agreement with Dassault Systems. By expanding the use of Dassault Systems’ 3DEXPERIENCE platform and various other industry solutions, and combining them with trans cosmos’s expertise in consulting and service delivery, the two companies will contribute to driving value for the end customer.

In January 2023, Schrödinger expands neuroscience work with BMS, Otsuka partnerships. With Bristol Myers Squibb, the company is expanding its previous partnership to include a new discovery program in neurology. Schrödinger previously inked a research deal with the drugmaker in late 2020, with plans to explore pharmaceutical targets in kidney cancer and KRAS-driven tumors, as well as other diseases in neurology and immunology.

Products Covered
• Software
• Services
• Other Products

Approaches Covered
• Molecular Mechanics Approach
• Quantum chemistry Approach
• Other Approaches

Applications Covered
• Drug Development
• Drug Discovery
• Other Applications

End Users Covered
• Pharmaceutical and Biotechnology Companies
• Research Centers and Academic Institutions
• Other End Users

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements